S. Cullinan

发表

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5‐fluorouracil, prednisone adjuvant therapy in premenopausal women with node‐positive breast cancer

J. Ingle, J. Krook, L. Wold, 1989, Cancer.

Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.

J. K. Martin, J. Ingle, J. Krook, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

D. Schaid, J. Ingle, J. Krook, 1989, Cancer.

Phase II Studies of Bleomycin, Cyclophosphamide, Doxorubicin and Cisplatin, and Bleomycin and Cisplatin in Advanced Cervical Carcinoma

J. Edmonson, G. Malkasian, J. A. Jefferies, 1988, American journal of clinical oncology.

Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure

J. Ingle, L. Kvols, J. Laurie, 1985, American journal of clinical oncology.

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5‐fluorouracil, doxorubicin, and cisplatin

J. Krook, B. Norris, H. Wieand, 1990, Cancer.

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

D. Schaid, J. Ingle, J. Krook, 1991, Cancer.

Alternating Chemotherapy With or Without VP‐16 in Extensive‐Stage Small‐Cell Lung Cancer

J. O'fallon, J. Jett, J. Laurie, 1989, American journal of clinical oncology.

Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.

J. Ingle, J. Laurie, S. Green, 1985, Cancer treatment reports.

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

J. Laurie, M. O’connell, H. Wieand, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neuromyopathy of cyanide intoxication due to “laetrile” (amygdalin). A clinicopathologic study

J. Mclean, S. Cullinan, U. Kalyanaraman, 1983, Cancer.

Phase II study of cytosine arabinoside in advanced large bowel cancer.

M. O’connell, R. Hahn, J. Rubin, 1977, Cancer treatment reports.

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.

T. Fleming, J. Laurie, C. Moertel, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.

T. Fleming, J. Krook, J. Rubin, 1985, JAMA.

Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.

D. Schaid, J. Ingle, J. Mailliard, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.

J. Laurie, A. Schutt, J. Gerstner, 1983, Cancer treatment reports.

Acute pulmonary hypersensitivity to carbamazepine.

S. Cullinan, G. Bower, 1975, Chest.

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).

G. Rosner, M. Ratain, D. Hollis, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.

R. Morton, E. Creagan, M. Chang, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer

J. O'fallon, J. Buckner, J. Ingle, 1989, Breast Cancer Research and Treatment.

Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas.

T. Fleming, J. Edmonson, G. Malkasian, 1985, Cancer treatment reports.

FAM therapy for advanced gastric cancer: an ideal standard?

C. Moertel, S. Cullinan, 1985, Journal of Clinical Oncology.

A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.

T. Fleming, J. Jett, J. Laurie, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.

T. Fleming, R. Eagan, T. Elliott, 1984, Cancer treatment reports.